semaglutide and brain health Frontiers Could diabetes and weight loss

Tirzepatide offers a fundamentally different approach

FDA scrutiny of compounded dupes is increasing as shortages ease

CNBC also reports that a study found that, now that Wegovy is approved to treat heart disease in obese patients, more than 3 million Americans on Medicare could be eligible for prescription coverage of these drugs, noting that the programs budget could be strained as Wegovy is now covered by their Part D prescription plan

[DOI] [PubMed] [Google Scholar] 8.Balenovic D., Bencic M.L., Udovicic M., Simonji K., Hanzevacki J.S., Barisic I., Kranjcevic S., Prkacin I., Coric V., Brcic L., et al

Weight regain can occur if lifestyle changes are not sustained